Endologix, Inc. (ELGX) Posts Q1 Loss of 7c/Share; Reaffirms Outlook

Endologix, Inc. (NASDAQ: ELGX) reported Q1 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $24.5 million versus the consensus estimate of $23.29 million.

Endologix, Inc. reaffirmed FY2012 guidance.

For earnings history and earnings-related data on Endologix, Inc. (ELGX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance